<searchTitle>Oncologic Drugs Advisory Committee; Amendment of Notice; Federal Register Vol. 74, Issue </searchTitle>
<granuleClass>NOTICE</granuleClass>
<accessId>E9-21556</accessId>
<agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
<agency order="2">Food and Drug Administration</agency>
<departmentDoc>Docket No. FDA-2009-N-0664</departmentDoc>
<billingCode>4160-01-S</billingCode>
<frDocNumber>E9-21556</frDocNumber>
<action>Notice.</action>
<contact>Nicole Vesely, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-6793, FAX: 301-827-6776, e-mail: nicole.vesely@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512542. Please call the Information Line for up-to-date information on this meeting.</contact>
<tocSubject1>Meetings:</tocSubject1>
<tocDoc>Oncologic Drugs Advisory Committee
, </tocDoc>
<emailRef>nicole.vesely@fda.hhs.gov</emailRef>